NO20024924L - Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner - Google Patents

Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner

Info

Publication number: NO20024924L
Authority: NO; Norway
Prior art keywords: hypertrophy; bradycardial; substances; treatment; connection
Prior art date: 2000-04-13

Application number

NO20024924A

Other languages

English (en)

Other versions

NO20024924D0 (no

NO330311B1 (no

Inventor

Juergen Dommgen

Brian Guth

Randolph Seidler

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-13

Filing date

2002-10-11

Publication date

2002-10-11

2002-10-11 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2002-10-11 Publication of NO20024924L publication Critical patent/NO20024924L/no

2002-10-11 Publication of NO20024924D0 publication Critical patent/NO20024924D0/no

2011-03-28 Publication of NO330311B1 publication Critical patent/NO330311B1/no

Links

208000031229 Cardiomyopathies Diseases 0.000 title abstract 2
206010020880 Hypertrophy Diseases 0.000 title abstract 2
239000002547 new drug Substances 0.000 title 1
239000000126 substance Substances 0.000 title 1
OBUFMJDDZTXJPY-NRFANRHFSA-N 3-[[(3s)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1h-3-benzazepin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1CCN1C[C@@H](CN2C(CC3=CC(OC)=C(OC)C=C3CC2)=O)CCC1 OBUFMJDDZTXJPY-NRFANRHFSA-N 0.000 abstract 2
108090000312 Calcium Channels Proteins 0.000 abstract 1
102000003922 Calcium Channels Human genes 0.000 abstract 1
206010007572 Cardiac hypertrophy Diseases 0.000 abstract 1
108091006146 Channels Proteins 0.000 abstract 1
241000282326 Felis catus Species 0.000 abstract 1
239000002876 beta blocker Substances 0.000 abstract 1
230000000059 bradycardiac effect Effects 0.000 abstract 1
239000002371 cardiac agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229950010208 cilobradine Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
206010020871 hypertrophic cardiomyopathy Diseases 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20024924A 2000-04-13 2002-10-11 Bradykardiale substanser for behandling av myokardiale sykdommer som ledsages av hypertrofi. NO330311B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10018401A DE10018401A1 (de)	2000-04-13	2000-04-13	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de)	2000-04-13	2001-04-07	Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (3)

Publication Number	Publication Date
NO20024924L true NO20024924L (no)	2002-10-11
NO20024924D0 NO20024924D0 (no)	2002-10-11
NO330311B1 NO330311B1 (no)	2011-03-28

Family

ID=7638652

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024924A NO330311B1 (no)	2000-04-13	2002-10-11	Bradykardiale substanser for behandling av myokardiale sykdommer som ledsages av hypertrofi.

Country Status (33)

Country	Link
US (2)	US7208508B2 (no)
EP (2)	EP1276476B1 (no)
JP (1)	JP3905386B2 (no)
KR (1)	KR20020089453A (no)
CN (1)	CN1245963C (no)
AT (1)	ATE330588T1 (no)
AU (2)	AU7048401A (no)
BG (1)	BG65816B1 (no)
BR (1)	BR0109996A (no)
CA (2)	CA2575059A1 (no)
CY (1)	CY1105081T1 (no)
CZ (1)	CZ300549B6 (no)
DE (2)	DE10018401A1 (no)
DK (1)	DK1276476T3 (no)
EA (1)	EA006977B1 (no)
EE (1)	EE05099B1 (no)
ES (1)	ES2266216T3 (no)
HR (1)	HRP20020815A2 (no)
HU (1)	HU228387B1 (no)
IL (2)	IL152103A0 (no)
ME (1)	MEP45908A (no)
MX (1)	MXPA02009935A (no)
NO (1)	NO330311B1 (no)
NZ (1)	NZ521934A (no)
PL (1)	PL215235B1 (no)
PT (1)	PT1276476E (no)
RS (1)	RS51478B (no)
SI (1)	SI1276476T1 (no)
SK (1)	SK286075B6 (no)
TR (1)	TR200202326T2 (no)
UA (1)	UA78679C2 (no)
WO (1)	WO2001078699A2 (no)
ZA (1)	ZA200208162B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10018401A1 (de)	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) *	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
ES2211846T3 (es) *	2002-07-25	2004-07-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
AU2004208615C1 (en) *	2003-01-31	2010-05-13	Daiichi Sankyo Company, Limited	Medicine for prevention of and treatment for arteriosclerosis and hypertension
TWI405580B (zh) *	2005-06-27	2013-08-21	Sankyo Co	含有血管收縮素ｉｉ接受器拮抗劑及鈣通道阻斷劑之醫藥調配物
US20090247572A1 (en) *	2005-08-23	2009-10-01	Koichi Wada	Agent for treating atrial fibrillation
EP1762179A1 (en)	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) *	2006-09-15	2013-06-21	Daiichi Sankyo Co Ltd	奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en)	2006-10-06	2008-04-09	Boehringer Ingelheim Vetmedica Gmbh	Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
PL2432452T3 (pl)	2009-05-20	2017-07-31	Boehringer Ingelheim Vetmedica Gmbh	Farmaceutyczny pitny roztwór telmisartanu
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) *	2011-02-17	2013-08-20	한국과학기술연구원	심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
MX2014001556A (es) *	2011-08-12	2014-03-31	Boehringer Ingelheim Vetmed	Composicion farmaceutica de sabor enmascarado.
EP2953612A1 (en)	2013-02-11	2015-12-16	Boehringer Ingelheim Vetmedica GmbH	Kit-of-parts
PL3648761T3 (pl)	2017-07-07	2024-07-22	Boehringer Ingelheim Vetmedica Gmbh	Telmisartan do profilaktyki lub leczenia nadciśnienia u kotów
KR102398532B1 (ko)	2020-07-20	2022-05-13	한림대학교 산학협력단	중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko)	2020-07-20	2021-12-01	한림대학교 산학협력단	중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE759125A (fr)	1969-11-19	1971-05-18	Boehringer Sohn Ingelheim	Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de)	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3541811A1 (de)	1985-11-27	1987-06-04	Thomae Gmbh Dr K	Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en)	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de)	1987-10-30	1989-05-11	Thomae Gmbh Dr K	Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de)	1988-02-24	1989-09-07	Thomae Gmbh Dr K	Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) *	1991-12-20	1994-05-03	Warner-Lambert Company	Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) *	1993-09-02	1997-05-10	Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско	Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
HUT74610A (en)	1993-09-24	1997-01-28	Procter & Gamble	Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds, pharmaceutical compositions containing them, process for producing the same and intermediate
US5595987A (en) *	1994-07-22	1997-01-21	The Trustees Of Columbia University In The City Of New York	Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) *	1997-06-04	2000-07-04	University Of Florida Research Foundation, Inc.	Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de)	1997-09-22	1999-03-25	Hoechst Marion Roussel De Gmbh	Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
TR200100062T2 (tr) *	1998-07-10	2001-06-21	Novartis Ag	Valsartan ve kalsiyum kanalı bloklayıcısının anti-hipertensif kombinasyonu
DE10018401A1 (de)	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) *	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
CA2435526A1 (en)	2002-07-25	2004-01-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) *	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography

2000
- 2000-04-13 DE DE10018401A patent/DE10018401A1/de not_active Withdrawn
2001
- 2001-04-07 PL PL357827A patent/PL215235B1/pl unknown
- 2001-04-07 NZ NZ521934A patent/NZ521934A/en not_active IP Right Cessation
- 2001-04-07 EE EEP200200590A patent/EE05099B1/xx not_active IP Right Cessation
- 2001-04-07 BR BR0109996-5A patent/BR0109996A/pt not_active Application Discontinuation
- 2001-04-07 AT AT01949281T patent/ATE330588T1/de active
- 2001-04-07 EP EP01949281A patent/EP1276476B1/de not_active Expired - Lifetime
- 2001-04-07 EP EP06111485A patent/EP1666042A3/de not_active Withdrawn
- 2001-04-07 EA EA200201053A patent/EA006977B1/ru not_active IP Right Cessation
- 2001-04-07 CN CNB018079598A patent/CN1245963C/zh not_active Expired - Fee Related
- 2001-04-07 US US10/257,481 patent/US7208508B2/en not_active Expired - Fee Related
- 2001-04-07 DK DK01949281T patent/DK1276476T3/da active
- 2001-04-07 CA CA002575059A patent/CA2575059A1/en not_active Abandoned
- 2001-04-07 PT PT01949281T patent/PT1276476E/pt unknown
- 2001-04-07 SK SK1458-2002A patent/SK286075B6/sk not_active IP Right Cessation
- 2001-04-07 WO PCT/EP2001/004034 patent/WO2001078699A2/de not_active Ceased
- 2001-04-07 HR HRP20020815 patent/HRP20020815A2/hr not_active Application Discontinuation
- 2001-04-07 HU HU0300917A patent/HU228387B1/hu not_active IP Right Cessation
- 2001-04-07 ME MEP-459/08A patent/MEP45908A/xx unknown
- 2001-04-07 KR KR1020027013688A patent/KR20020089453A/ko not_active Ceased
- 2001-04-07 IL IL15210301A patent/IL152103A0/xx unknown
- 2001-04-07 JP JP2001576000A patent/JP3905386B2/ja not_active Expired - Fee Related
- 2001-04-07 MX MXPA02009935A patent/MXPA02009935A/es active IP Right Grant
- 2001-04-07 AU AU7048401A patent/AU7048401A/xx active Pending
- 2001-04-07 RS YUP-769/02A patent/RS51478B/sr unknown
- 2001-04-07 CA CA002404120A patent/CA2404120C/en not_active Expired - Fee Related
- 2001-04-07 DE DE50110262T patent/DE50110262D1/de not_active Expired - Lifetime
- 2001-04-07 CZ CZ20023752A patent/CZ300549B6/cs not_active IP Right Cessation
- 2001-04-07 TR TR2002/02326T patent/TR200202326T2/xx unknown
- 2001-04-07 ES ES01949281T patent/ES2266216T3/es not_active Expired - Lifetime
- 2001-04-07 SI SI200130616T patent/SI1276476T1/sl unknown
- 2001-04-07 AU AU2001270484A patent/AU2001270484B2/en not_active Ceased
- 2001-07-04 UA UA2002118949A patent/UA78679C2/uk unknown
2002
- 2002-09-13 BG BG107103A patent/BG65816B1/bg unknown
- 2002-10-03 IL IL152103A patent/IL152103A/en not_active IP Right Cessation
- 2002-10-10 ZA ZA200208162A patent/ZA200208162B/en unknown
- 2002-10-11 NO NO20024924A patent/NO330311B1/no not_active IP Right Cessation
2006
- 2006-07-07 CY CY20061100956T patent/CY1105081T1/el unknown
2007
- 2007-03-12 US US11/684,974 patent/US20070155679A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EA006977B1 (ru)	2006-06-30
CZ20023752A3 (cs)	2003-03-12
IL152103A (en)	2008-07-08
WO2001078699A3 (de)	2002-06-20
CZ300549B6 (cs)	2009-06-10
EA200201053A1 (ru)	2003-02-27
HU228387B1 (en)	2013-03-28
WO2001078699A2 (de)	2001-10-25
MXPA02009935A (es)	2003-02-12
JP2003535050A (ja)	2003-11-25
NO20024924D0 (no)	2002-10-11
US20040014795A1 (en)	2004-01-22
EE05099B1 (et)	2008-12-15
EP1666042A2 (de)	2006-06-07
PL357827A1 (en)	2004-07-26
AU7048401A (en)	2001-10-30
EP1276476B1 (de)	2006-06-21
YU76902A (sh)	2006-05-25
CA2404120C (en)	2008-01-22
IL152103A0 (en)	2003-07-31
PT1276476E (pt)	2006-09-29
ATE330588T1 (de)	2006-07-15
EP1276476A2 (de)	2003-01-22
ES2266216T3 (es)	2007-03-01
ZA200208162B (en)	2003-10-17
NZ521934A (en)	2007-05-31
CN1422153A (zh)	2003-06-04
HUP0300917A2 (hu)	2003-08-28
PL215235B1 (pl)	2013-11-29
DE10018401A1 (de)	2001-10-25
HUP0300917A3 (en)	2009-04-28
US7208508B2 (en)	2007-04-24
AU2001270484B2 (en)	2007-01-25
MEP45908A (en)	2011-02-10
DE50110262D1 (de)	2006-08-03
RS51478B (sr)	2011-04-30
SK286075B6 (sk)	2008-03-05
SK14582002A3 (sk)	2003-03-04
CA2404120A1 (en)	2001-10-25
HRP20020815A2 (en)	2004-12-31
EP1666042A3 (de)	2006-06-21
EE200200590A (et)	2004-04-15
BG65816B1 (bg)	2010-01-29
KR20020089453A (ko)	2002-11-29
CY1105081T1 (el)	2009-11-04
NO330311B1 (no)	2011-03-28
CN1245963C (zh)	2006-03-22
DK1276476T3 (da)	2006-08-14
CA2575059A1 (en)	2001-10-25
TR200202326T2 (tr)	2003-03-21
BG107103A (bg)	2003-04-30
SI1276476T1 (sl)	2006-10-31
US20070155679A1 (en)	2007-07-05
BR0109996A (pt)	2003-05-27
UA78679C2 (en)	2007-04-25
JP3905386B2 (ja)	2007-04-18

Legal Events

Date	Code	Title	Description
2013-12-02	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20024924L (no)	2002-10-11	Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
ES2164040T1 (es)	2002-02-16	Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
BRPI0108977B8 (pt)	2021-05-25	compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
EA200501496A1 (ru)	2006-06-30	Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
TW200505901A (en)	2005-02-16	Muscarinic agonists
PT913156E (pt)	2005-08-31	Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
EP1889614A3 (en)	2010-09-22	Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2002000210A3 (en)	2002-10-24	Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease
PT1900362E (pt)	2011-03-09	Derivados de alfa-aminoamida úteis no tratamento de perturbações aditivas
GB2352972A (en)	2001-02-14	Use of dexmedetomidine for icu sedation
BR9910899A (pt)	2001-10-09	Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
WO2002034267A8 (de)	2002-05-23	Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
BR0111982A (pt)	2003-10-28	Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão
BR0108261A (pt)	2003-03-05	Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
NO20005223L (no)	2000-11-20	Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
MXPA03009099A (es)	2004-02-12	Agonistas de kappa-opiato para tratamiento de transtornos de vejiga.
US6214849B1 (en)	2001-04-10	Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans
BRPI0414112A (pt)	2006-10-31	uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono
EP1632235A3 (en)	2006-06-14	Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
PL1514545T3 (pl)	2008-07-31	Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich
ECSP003771A (es)	2001-07-27	Metodo para prevenir la diarrea
EP1787984A3 (en)	2009-12-02	Azacyclic compounds for use in the treatment of serotonin related diseases
BRPI0503488A (pt)	2006-03-07	agente de tratamento para sìndrome de intestino irritável com diarréia predominante
RU2002103977A (ru)	2003-10-10	Способ лечения острого гнойного пиелонефрита
RU99118112A (ru)	2001-06-20	Способ лечения больных с невротическими расстройствами препаратом "миелопид"